William M Gallagher Selected Research

Ovarian Epithelial Carcinoma

9/2011	The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
5/2009	The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William M Gallagher Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 12/2004
55	Breast Neoplasms (Breast Cancer) 10/2022 - 08/2005
16	Melanoma (Melanoma, Malignant) 01/2022 - 11/2005
12	Neoplasm Metastasis (Metastasis) 10/2022 - 04/2007
12	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 07/2011
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2011
8	Triple Negative Breast Neoplasms 04/2020 - 04/2014
6	Inflammation (Inflammations) 01/2021 - 01/2011
4	Hypoxia (Hypoxemia) 01/2019 - 11/2006
3	Carcinoma (Carcinomatosis) 02/2022 - 09/2004
3	Disease Progression 01/2021 - 02/2010
3	Ovarian Neoplasms (Ovarian Cancer) 10/2014 - 09/2011
3	Hyperplasia 06/2006 - 03/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 04/2007
2	Carcinogenesis 12/2021 - 01/2021
2	Ovarian Epithelial Carcinoma 09/2011 - 05/2009
1	Lymphatic Metastasis 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenoma (Adenomas) 12/2021
1	Dysbiosis 01/2021
1	Uveal melanoma 10/2020
1	Obesity 09/2020
1	Endometrial Neoplasms (Endometrial Cancer) 09/2020

Drug/Important Bio-Agent (IBA)

42	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2007
29	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2007
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2005
10	Estrogen ReceptorsIBA 01/2022 - 11/2006
9	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2008
8	Pharmaceutical PreparationsIBA 01/2018 - 02/2007
7	Messenger RNA (mRNA)IBA 02/2022 - 11/2005
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 09/2011
5	Serum Response FactorIBA 01/2022 - 05/2013
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2010
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2011
4	EnzymesIBA 04/2020 - 04/2010
4	Bevacizumab (Avastin)FDA Link 01/2020 - 06/2017
4	Biological ProductsIBA 06/2015 - 04/2007
4	ProteomeIBA 01/2015 - 02/2007
3	Small Interfering RNA (siRNA)IBA 02/2022 - 09/2009
3	Formaldehyde (Formol)FDA Link 01/2022 - 07/2017
3	ParaffinIBA 01/2022 - 07/2017
3	AcidsIBA 12/2021 - 04/2013
3	human ERBB2 proteinIBA 11/2021 - 10/2010
3	Lapatinib (GW572016)FDA Link 01/2021 - 10/2011
3	Peptides (Polypeptides)IBA 06/2015 - 04/2013
3	Tamoxifen FDA LinkGeneric 01/2011 - 05/2009
3	SurvivinIBA 11/2010 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 10/2010
2	Hormones (Hormone)IBA 01/2021 - 05/2013
2	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 11/2015
2	AntioxidantsIBA 04/2020 - 07/2014
2	quininibIBA 06/2019 - 10/2016
2	Sunitinib (Sutent)FDA Link 01/2019 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2018 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 03/2018 - 01/2016
2	PolyhydroxyalkanoatesIBA 06/2015 - 04/2013
2	Complement System Proteins (Complement)IBA 06/2015 - 11/2011
2	Phenobarbital (Luminal)FDA Link 10/2013 - 01/2013
2	AntibodiesIBA 04/2013 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2012 - 09/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 09/2011
2	ChemokinesIBA 01/2012 - 09/2011
2	CytokinesIBA 01/2012 - 09/2011
2	SOXC Transcription FactorsIBA 09/2011 - 05/2009
2	Oxygen (Dioxygen)IBA 09/2011 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 04/2011 - 04/2007
2	Oxidoreductases (Dehydrogenase)IBA 01/2011 - 04/2010
2	Indicators and Reagents (Reagents)IBA 11/2010 - 05/2008
2	A-Form DNA (A-DNA)IBA 10/2010 - 09/2008
2	Cyclin EIBA 04/2007 - 11/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	Gemcitabine FDA Link 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	lestaurtinibIBA 01/2022
1	propionic acid (potassium propionate)IBA 12/2021
1	2-methylbutanoic acidIBA 12/2021
1	Volatile Fatty AcidsIBA 12/2021
1	n-pentanoic acid (valeric acid)IBA 12/2021
1	UbiquitinIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	AfatinibIBA 01/2021
1	neratinibIBA 01/2021
1	pertuzumabIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	enzalutamideIBA 11/2020
1	Deubiquitinating EnzymesIBA 11/2020
1	venetoclaxIBA 10/2020
1	AS 8IBA 10/2020
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020

Therapy/Procedure

32	Therapeutics 01/2022 - 02/2006
10	Drug Therapy (Chemotherapy) 02/2022 - 11/2005
3	Neoadjuvant Therapy 05/2020 - 02/2007
3	Castration 02/2014 - 10/2011
2	Immunotherapy 01/2022 - 01/2018
2	Prostatectomy (Retropubic Prostatectomy) 11/2015 - 05/2011
2	Photochemotherapy (Photodynamic Therapy) 02/2012 - 09/2009
2	Stents 06/2006 - 04/2004
1	Cystectomy 02/2022
1	Traction 10/2020